Screener
Immix Biopharma, Inc. IMMX Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-021764
FAQ
- What is Immix Biopharma, Inc.'s shares (diluted)?
- Immix Biopharma, Inc. (IMMX) reported shares (diluted) of 55.4M in Q1 2026.
- How has Immix Biopharma, Inc.'s shares (diluted) changed year-over-year?
- Immix Biopharma, Inc.'s shares (diluted) increased by 86.4% year-over-year, from 29.7M to 55.4M.
- What is the long-term trend for Immix Biopharma, Inc.'s shares (diluted)?
- Over 2 years (2023 to 2025), Immix Biopharma, Inc.'s shares (diluted) has grown at a 38.6% compound annual growth rate (CAGR), from 64.9M to 124.6M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Immix Biopharma, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude